Literature DB >> 29732918

Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981-2013) by stage at presentation.

Aliyah Gauri1, Sarah E Messiah1,2, Layla A Bouzoubaa1,3, Kevin J Moore1, Tulay Koru-Sengul1,3.   

Abstract

Objective: Florida has one of the highest cervical cancer mortality rates and socioeconomically diverse populations in the United States. We used statewide population-based cancer registry data to assess disparities in cervical cancer stage at diagnosis. Design: Primary invasive adult female cervical cancer patients in the Florida Cancer Data Registry (1981-2013) were linked with 2000 United States Census data. Early (localized) and advanced (regional and distant) stage at diagnosis was assessed by age, race, ethnicity, neighborhood socioeconomic-, marital-, and smoking- status. Univariate and multivariable logistic regression models were fit to identify factors associated with the risk of advanced cervical cancer stage at diagnosis. Adjusted odds ratios (aOR) and corresponding 95% confidence intervals (95%CI) were calculated.
Results: Of 18,279 women (meanage 51.3 years old), most were non-Hispanic (83.5%), white (79.1%), middle-low neighborhood socioeconomic status (NSES) (34.7%), married (46.0%), and never smoked (56.0%). Higher odds of advanced stage was observed for blacks (aOR: 1.42, 95%CI: 1.30-1.55, p < 0.001) compared to whites, Hispanics (1.15, 1.06-1.25, p = 0.001) compared to non-Hispanics, and middle-low (1.13, 1.02-1.25, p = 0.02) and low NSES (1.42, 1.28-1.57, p < 0.001) compared to high NSES. Previously (1.30, 1.21-1.39, p < 0.001) and never married (1.37, 1.27-1.48, p < 0.001) had higher odds of presenting with advanced stage versus married women. Never smokers had decreased odds of presenting with advanced stage compared to women with history of (1.41, 1.32-1.52, p < 0.001) or current (1.29, 1.18-1.42, p < 0.001)smoking status. Conclusions: There are cancer disparities in women of black race, Hispanic ethnicity and of middle-low and lowest NSES in Florida. Evidence-based interventions targeting these vulnerable groups are needed. Abbreviations: HPV: Human Papilloma Virus; CDC: Center for Disease Control and Prevention; SES: socioeconomic status; FCDS: Florida Cancer Data System; NSES: Neighborhood Socioeconomic Status; NPCR: National Program of Cancer Registries; IRB: Institutional Review Board; ACS: American Community Survey; SEER: Surveillance, Epidemiology and End Results; OR: Odds Ratio; CI: Confidence Interval.

Entities:  

Keywords:  Cervical cancer; Florida; cancer stage; disparities; ethnicity; race

Year:  2018        PMID: 29732918     DOI: 10.1080/13557858.2018.1471669

Source DB:  PubMed          Journal:  Ethn Health        ISSN: 1355-7858            Impact factor:   2.772


  6 in total

1.  Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.

Authors:  Rahma S Mkuu; Stephanie A Staras; Sarah M Szurek; Dalila D'Ingeo; Mary A Gerend; Dianne L Goede; Elizabeth A Shenkman
Journal:  BMC Cancer       Date:  2022-03-09       Impact factor: 4.430

2.  SFN Enhanced the Radiosensitivity of Cervical Cancer Cells via Activating LATS2 and Blocking Rad51/MDC1 Recruitment to DNA Damage Site.

Authors:  Shiyu Wang; Yanan Wang; Xiangnan Liu; Yongbin Yang; Sufang Wu; Yuan Liu
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

3.  LncRNA FAM13A-AS1 Regulates Proliferation and Apoptosis of Cervical Cancer Cells by Targeting miRNA-205-3p/DDI2 Axis.

Authors:  Zhiqin Qiu; Lin He; Feng Yu; Hui Lv; Ye Zhou
Journal:  J Oncol       Date:  2022-06-23       Impact factor: 4.501

4.  Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis.

Authors:  Yiran Zhang; Xu Guo; Guowen Wang; Wenjuan Ma; Ruoyan Liu; Xiuxin Han; Lili Li; Vladimir P Baklaushev; Andrey S Bryukhovetskiy; Wan Wang; Xin Wang; Chao Zhang
Journal:  Med Sci Monit       Date:  2018-09-12

5.  Factors Associated with Duration of Overall Treatment Time for Cervical Cancer Treated with Definitive Chemoradiotherapy.

Authors:  Vladimir Valakh; Bryan C Coopey
Journal:  Cureus       Date:  2019-10-21

6.  Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer.

Authors:  Grace Lee; Edward Christopher Dee; E John Orav; Daniel W Kim; Paul L Nguyen; Alexi A Wright; Miranda B Lam
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.